Search Results

Showing results 11 - 20 of 1983.
Sort By: Date ▼

CMS OKs Washington's 'subscription' payment model for hepatitis C drugs

June 14, 2019


CMS on Wednesday approved Washington's plan to negotiate value-based drug agreements with the makers of hepatitis C treatments under a subscription-like model.

Can medical marijuana reduce fatal opioid overdoses? Maybe not.

June 13, 2019


A study published Monday casts doubt on claims that medical marijuana legalization could reduce opioid-related overdose deaths by giving patients an alternative pain treatment.

Healthy people at risk of HIV infection should take PrEP, USPSTF now recommends

June 13, 2019


The United States Preventive Services Task Force on Tuesday for the first time recommended that doctors should offer pre-exposure prophylaxis to healthy people at risk of HIV infection.

Opioid suits lead Insys to file for bankruptcy—and other drugmakers could follow

June 12, 2019


Insys Therapeutics on Monday filed for Chapter 11 bankruptcy protection, just days after the drugmaker agreed to pay $225 million to settle allegations that it paid kickbacks to physicians to encourage them to prescribe its highly addictive opioid—and some observers say similar allegations could cause other drugmakers to follow Insys' lead.

CMS wants to know: How can it reduce clinicians' administrative burdens?

June 11, 2019


CMS on Thursday issued a request for information seeking new recommendations on how the agency can continue to help reduce administrative burdens on providers and lower health care costs.

'Accelerated approval' can rush new cancer drugs to patients. But are they actually effective?

June 11, 2019


Cancer drugs that are granted accelerated approval by FDA often do not show clear outcomes benefits when more rigorous clinical trials are conducted, according to a study published last month.

Weekly Line: 'Evil' or scientifically sound? Inside the debate over Pfizer's Alzheimer's research.

June 7, 2019


About 5.8 million U.S. residents have Alzheimer's disease, and CDC projects that number will reach 13.9 million by 2060 as baby boomers age. Yet, despite the disease's wide reach and devastating effects, there's still no proven treatment.

FDA unveils pilot program to help cancer patients access experimental drugs

June 5, 2019


FDA's Oncology Center of Excellence on Monday announced a new pilot program that will serve as a single point of contact for oncology health care professionals working to help their patients access experimental drugs under FDA's Expanded Access, or "compassionate use," pathway.

Results Page: [Previous] 1 2 3 4 5  ... [Next]